查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433624

獸用腎病變市場規模、佔有率、趨勢分析報告：按類型、動物類型、途徑、適應症、分銷管道、地區和細分市場預測，2024-2030 年

Veterinary Renal Disease Market Size, Share & Trends Analysis Report By Type, By Animal Type (Canine, Feline, Bovine, Equine, Others), By Route of Administration, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 154 Pages | 商品交期: 2-10個工作天內

價格

獸醫腎病變市場成長與趨勢：

根據Grand View Research, Inc.最新報告顯示，到2030年，全球獸用腎病變市場規模預計將達229億美元，預計2024年至2030年複合年成長率為5.49%。

腎臟疾病盛行率的上升和採用治療性飲食作為治療方法是該市場的主要成長動力。慢性腎臟病（CKD）、腎衰竭等腎臟疾病會對動物的腎臟系統造成不可逆的損害。儘管這種疾病沒有明確的治療方法，但透過不同類型的治療方法進行適當的管理可以改善動物的生活。最重要的方法之一是透過治療性飲食進行營養管理。

另一個關鍵的市場促進因素是人工智慧在獸醫腎臟疾病診斷和治療中的日益採用。診斷影像在獸醫學中發揮著重要作用，它不僅為疾病和損傷的評估提供重要資料，而且還為常規預防措施提供重要數據。事實證明，人工智慧是一種極其有價值的工具，尤其是在放射科醫生短缺的地區。更快和增強的診斷能力等相關優勢預計將增加人工智慧的採用，從而在不久的將來對市場產生積極影響。

動物醫學領域的知名公司瑪氏早已進入將人工智慧應用於獸醫診療領域。 2019年，Antech Diagnostics（火星）推出了尖端診斷工具RenalTech。 RenalTech 使用人工智慧 (AI) 評估寵物醫療記錄資料，以預測貓患慢性腎臟病(CKD) 的風險，最多可比臨床診斷提前兩年。

此外，產品系列擴張、併購和整合活動等市場動態預計將為該市場提供成長基礎。例如，2023 年 9 月，Elanco Animal Health 的 Varenzin-CA1（莫利司他口服混懸液）獲得美國FDA 有條件核准，用於治療患有慢性腎臟病（CKD）的貓的非再生性貧血。此外，2023 年 12 月，Neogen 公司與佛羅裡達州米亞卡市的 TerraNova 馬術中心合作，成為該設施診斷測試產品的官方生物安全提供者。

獸醫腎臟病市場報告亮點

  • 按類型分類，治療細分市場將在 2023 年以 68.99% 的最大收益佔有率引領市場。這是由於可用的治療方法豐富以及全球寵物數量不斷成長。
  • 按動物類型分類，貓科動物預計在預測期內將以最快的複合年成長率成長。
  • 根據給藥途徑，口服細分市場將在 2023 年佔據最大的收益佔有率，而注射細分市場預計在預測期內複合年成長率最快。
  • 根據跡象，腎炎細分市場預計將在 2023 年佔據最大的收益佔有率，達到 29.74%，預計腎炎細分市場在預測期內的複合年成長率第二快。
  • 動物各種腎臟併發症率的上升、寵物食品的大量使用以及疾病意識舉措的提高都促進了市場的成長。
  • 2023 年，北美市場佔據最大的收益佔有率。全部區域整體獸醫保健的重要性日益增加，被認為是推動市場擴張的關鍵因素。美國寵物產品協會估計，2023年至2024年，美國將有6,510萬個家庭擁有寵物。此外，飼主對動物健康以及為腎功能不全動物提供護理重要性的認知不斷提高，也推動了北美市場的擴張。
  • 2023 年 5 月，Dechra Pharmaceuticals 宣布了兩種支持老年貓腎臟健康的產品的商業權：Porus One 和 Add One。 Porus One 含有 Renaltec，這是一種選擇性吸收劑，可以吸收貓腸道中尿毒症毒素的前體，這些毒素通常會被健康的腎臟清除或調節。 Add One 是一種專為老年貓開發的濕貓零食，鼓勵它們吃 Poluswan，據說對喜歡乾糧的貓很有用。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章獸用腎病市場：變數、趨勢和範圍

  • 市場體系展望
  • 法律規範
  • 按主要物種和主要國家分類的寵物數量估計（2018-2023）
  • 2022 年及 2023 年美國寵物主人人口統計（世代）
  • 寵物腎臟疾病的盛行率
  • 產品價格分析
  • 消費者偏好分析
  • 獸用腎病變市場動態
  • 獸醫腎臟病市場：波特五力分析
  • 獸醫腎臟病市場：PESTEL 分析
  • COVID-19 影響分析

第4章 2018-2030 年類型估計與趨勢分析（百萬美元）

  • 按類型分類的獸醫腎臟病市場：要點
  • 2023年和2030年類型變化分析和市場佔有率
  • 按類型
  • 診斷
  • 治療

第5章 2018-2030年動物類型估算與趨勢分析（百萬美元）

  • 按動物類型分類的獸用腎病市場：要點
  • 2023年和2030年動物類型變化分析和市場佔有率
  • 依動物類型
  • 狗
  • 貓
  • 牛
  • 馬
  • 其他

第6章 2018-2030 年給藥途徑估算與趨勢分析（百萬美元）

  • 按給藥途徑分類的獸用腎病變市場：要點
  • 2023年及2030年行政途徑變化分析及市場佔有率
  • 依給藥途徑
  • 口服
  • 注射

第7章 2018-2030年指標估算與趨勢分析（百萬美元）

  • 按適應症分類的獸用腎病市場：重點
  • 2023年和2030年的指示變化分析和市場佔有率
  • 按指示
  • 腎衰竭
  • 慢性腎臟病（CKD）
  • 腎性膀胱炎
  • 腎結石
  • 腎炎
  • 其他

第8章 2018-2030年通路估算與趨勢分析（百萬美元）

  • 按分銷管道分類的獸用腎病市場：要點
  • 2023年及2030年通路波動分析及市場佔有率
  • 按分銷管道
  • 動物醫院/診所
  • 寵物專賣店
  • 電子商務
  • 其他

第 9 章 2018-2030 年區域估計與趨勢分析（百萬美元）

  • 區域展望
  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場、要點
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 丹麥
    • 挪威
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 科威特
    • 阿拉伯聯合大公國

第10章競爭形勢

  • 參與企業概況
  • 財務績效
  • 服務標竿
  • 市場參與企業分類
  • 2022年預計市場情勢分析（熱圖分析）
  • 策略規劃
    • 擴張
    • 併購
    • 夥伴關係與協作
    • 啟動/擴展服務
    • 其他
  • 公司簡介
    • Mars inc.
    • Nestle Purina Petcare
    • Hills Pet Nutrition.
    • JM Smucker.
    • General Mills
    • Zoetis Inc.
    • Merck &Co. Inc.
    • Elanco.
    • Phibro Animal Health Corporation.
    • Ceva Sante Animale
    • Boehringer Ingelheim Animal Health
    • Dechra Pharmceuticals
    • VetPharma
    • Vedco Inc.
    • Mission Pharmacal Company
    • Rayne Clinical Nutrition
    • Neogen Corporation.
    • Roquette Freres
    • JP Farma
    • Richmond Vet Pharma
    • IDEXX Laboratories Inc.
    • Fujifilm Holdings Corporation
    • Carestream Health.
    • Mindray Bio-Medical Electronics Co., Ltd.

第11章 要點

Product Code: GVR-4-68040-187-4

Veterinary Renal Disease Market Growth & Trends:

The global veterinary renal disease market size is anticipated to reach USD 22.90 billion by 2030 and it is projected to grow at a CAGR of 5.49% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of renal diseases coupled with adoption of therapeutic food as a treatment are key growth drivers for this market. Renal diseases like chronic kidney disease (CKD), renal failure, etc. cause irreversible damage to the renal system of animals. Despite no definite cure for this disease, proper management by various types of therapies can help in the betterment of animal life. One of the most prominent methods is that of nutritional management through therapeutic food.

Another crucial market propeller is the rising adoption of AI in veterinary renal disease diagnostics and treatment. Imaging plays a significant role in veterinary medicine by offering vital data for regular preventative measures as well as the assessment of disease and injury. AI can prove to be a very beneficial tool, especially in radiologist deficient geographies. Associated benefits such as faster and enhanced diagnostic capabilities is anticipated to increase adoption of AI and thereby influence positively on market in near future.

Mars Inc, which is a prominent player in the animal health space, has already stepped into the field of applying AI to veterinary diagnostics and treatment. Antech Diagnostics (Mars Inc.) introduced RenalTech, a cutting-edge diagnostic tool, in 2019. RenalTech uses artificial intelligence (AI) to evaluate pet medical record data and forecast a cat's risk of developing chronic kidney disease (CKD) up to two years ahead of an established clinical diagnosis.

Moreover, market dynamics such as product portfolio expansion, M&A, consolidation activities are further anticipated to provide growth platform to this market. For example, in September 2023, Elanco Animal Health received conditional U.S. FDA approval for Varenzin-CA1 (molidustat oral suspension), as the treatment to control non-regenerative anemia in cats with chronic kidney disease (CKD). Furthermore , in December 2023, Neogen Corporation partnered with the TerraNova Equestrian Center in Myakka City, Florida, making the company the official biosecurity provider of the facility for diagnostic testing products.

Veterinary Renal Disease Market Report Highlights:

  • Based on type, the treatment segment led the market with the largest revenue share of 68.99% in 2023, due to the wide array of treatments available coupled with ever growing population of pets globally
  • Based on animal type, the feline segment is expected to grow at the fastest CAGR over the forecast period
  • Based on route of administration, the oral segment held the largest revenue share in 2023 and the injectable segment is expected to have the fastest CAGR over the forecast period
  • Based on the indication, the renal cystitis segment held the largest revenue share of 29.74% in 2023 and nephritis segment is expected to have the second fastest CAGR over the forecast period
  • Rising prevalence of a variety of renal complications in animals, prominent usage of pet food, growing disease awareness initiatives are contributing to the market growth
  • North America accounted for the largest revenue share of the market in 2023. The increasing significance of animal health care in general throughout the region has been identified as a key factor propelling market expansion. The American Pet Products Association estimates that 65.1 million homes in the country have pets in 2023-2024. Moreover, growing pet owners' awareness of animal health and the significance of providing care for animals with renal disorders are fueling the market expansion in North America
  • In May 2023, Dechra Pharmaceuticals announced distribution rights of two products to support kidney health in senior cats - Porus One, and Add One. Porus One contains renaltec, a selective absorber that soaks up precursors of uremia toxins in the cat's intestines that would ordinarily be removed or regulated by healthy kidneys. Add One is a moist cat treat designed for senior cats, developed to encourage them to eat Porus One, and is said to be useful for cats that prefer dry food

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Regional Scope
    • 1.1.2 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information/Data Analysis
    • 1.4.1 Information Analysis
  • 1.5 Market Formulation & Visualization
  • 1.6 Data Validation & Publishing
  • 1.7 Model Details
    • 1.7.1 Approach 1: Commodity Flow Analysis
      • 1.7.1.1 Hybrid Market Estimation Model
    • 1.7.2 Approach 2: Volume-Price Analysis (Bottom-Up)
    • 1.7.3 Approach 3: Ancillary Market Analysis
    • 1.7.4 Global Market: Cagr Calculation
  • 1.8 List Of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Veterinary Renal Diseases Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Regulatory Framework
    • 3.2.1 North America
    • 3.2.2 Europe
    • 3.2.3 Asia Pacific
    • 3.2.4 Latin America
    • 3.2.5 Mea
  • 3.3 Estimated Pet Population By Key Species & Key Countries (2018-2023)
  • 3.4 U.S. Pet Owner Demographics, 2022 & 2023, By Generation
  • 3.5 Prevalence Of Pet Renal Diseases
  • 3.6 Product Price Analysis
  • 3.7 Consumer Preference Analysis
  • 3.8 Veterinary Renal Diseases Market Dynamics
    • 3.8.1 Market Driver Impact Analysis
      • 3.8.1.1 Rising Prevalence Of A Variety Of Renal Complications In Animals
      • 3.8.1.2 Prominent Usage Of Pet Food
      • 3.8.1.3 Growing Disease Awareness Initiatives
    • 3.8.2 Market Restraint Analysis
      • 3.8.2.1 Off-Label Use Of Drugs In Veterinary Treatment
      • 3.8.2.2 Lack Of Structured Regulations And Quality Control
  • 3.9 Veterinary Renal Diseases Market: Porter's 5 Forces Analysis
    • 3.9.1 Threat Of New Entrants: Moderate
    • 3.9.2 Threat Of Substitutes: Low To Moderate
    • 3.9.3 Bargaining Power Of Buyers: Moderate To High
    • 3.9.4 Bargaining Power Of Suppliers: Low
    • 3.9.5 Competitive Rivalry: High
  • 3.10 Veterinary Renal Diseases Market: Pestel Analysis
    • 3.10.1 Political & Legal
    • 3.10.2 Economic
    • 3.10.3 Social
    • 3.10.4 Technological
    • 3.10.5 Environmental
  • 3.11 Covid-19 Impact Analysis
    • 3.11.1 Pre & Current Impact And Future Scenario
    • 3.11.2 Impact Of Covid-19 On Market Players

Chapter 4 Type Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 4.1 Veterinary Renal Diseases Market By Type: Key Takeaways
  • 4.2 Type Movement Analysis & Market Share, 2023 & 2030
  • 4.3 Veterinary Renal Diseases Market Estimates & Forecast, By Type (USD Million)
  • 4.4 Diagnosis
    • 4.4.1 Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.1 Test Kits & Consumables
      • 4.4.1.1.1 Test Kits & Consumables Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.2 Instruments
      • 4.4.1.2.1 Instruments Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.5 Treatment
    • 4.5.1 Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1 Drugs
      • 4.5.1.1.1 Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1.1.2 Nsaids
      • 4.5.1.1.1.2.1 Nsaids Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1.1.3 Antibiotics
      • 4.5.1.1.1.3.1 Antibiotics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1.1.4 Cystine-Binding Agents
      • 4.5.1.1.1.4.1 Cystine Binding Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1.1.5 Diuretics
      • 4.5.1.1.1.5.1 Diuretics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1.1.6.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.2 Therapeutic Food Supplements
      • 4.5.1.2.1 Therapeutic Food Supplements Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.3 Ringer Lactate Solution
      • 4.5.1.3.1 Ringer Lacate Solution Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Animal Type Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 5.1 Veterinary Renal Diseases Market By Animal Type: Key Takeaways
  • 5.2 Animal Type Movement Analysis & Market Share, 2023 & 2030
  • 5.3 Veterinary Renal Diseases Market Estimates & Forecast, By Animal Type (USD Million)
  • 5.4 Canine
    • 5.4.1 Canine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5 Feline
    • 5.5.1 Feline Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6 Bovine
    • 5.6.1 Bovine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.7 Equine
    • 5.7.1 Equine Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.8 Others
    • 5.8.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Route Of Administration Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 6.1 Veterinary Renal Diseases Market By Indication: Key Takeaways
  • 6.2. Route Of Administration Movement Analysis & Market Share, 2023 & 2030
  • 6.3 Veterinary Renal Diseases Market Estimates & Forecast, By Route Of Administration (USD Million)
  • 6.4 Oral
    • 6.4.1 Oral Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5 Injectable
    • 6.5.1 Injectable Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Indication Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 7.1 Veterinary Renal Diseases Market By Indication: Key Takeaways
  • 7.2. Indication Movement Analysis & Market Share, 2023 & 2030
  • 7.3. Veterinary Renal Diseases Market Estimates & Forecast, By Indication (USD Million)
  • 7.4. Renal Failure
    • 7.4.1 Renal Failure Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5 Chronic Kidney Diseases (Ckd)
    • 7.5.1 Chronic Kidney Diseases (Ckd) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6 Renal Cystitis
    • 7.6.1 Renal Cystitis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7 Kidney Stones
    • 7.7.1 Kidney Stones Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8 Nephritis
    • 7.8.1 Nephritis Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.9 Others
    • 7.9.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Distribution Channel Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 8.1 Veterinary Renal Diseases Market By Distribution Channel: Key Takeaways
  • 8.2 Distribution Channel Movement Analysis & Market Share, 2023 & 2030
  • 8.3 Veterinary Renal Diseases Market Estimates & Forecast, By Distribution Channel (USD Million)
  • 8.4 Veterinary Hospitals & Clinics
    • 8.4.1 Veterinary Hospitals & Clinics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5 Pet Specialty Stores
    • 8.5.1 Pet Specialty Stores Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6 E-Commerce
    • 8.6.1 E-Commerce Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7 Others
    • 8.7.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9 Regional Estimates & Trend Analysis, 2018 - 2030 (USD Million)

  • 9.1 Regional Outlook
  • 9.2 Regional Market Share Analysis, 2023 & 2030
  • 9.3 Regional Marketplace, Key Takeaways
  • 9.4 Regional Marketplace, Key Takeaways
  • 9.5 North America
    • 9.5.1 Swot Analysis:
    • 9.5.2 North America Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3 U.S.
      • 9.5.3.1 Key Country Dynamics
      • 9.5.3.2 U.S. Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4 Canada
      • 9.5.4.1 Key Country Dynamics
      • 9.5.4.2 Canada Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6 Europe
    • 9.6.1 Swot Analysis:
    • 9.6.2 Europe Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3 Germany
      • 9.6.3.1 Key Country Dynamics
      • 9.6.3.2 Germany Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4 Uk
      • 9.6.4.1 Key Country Dynamics
      • 9.6.4.2 Uk Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.5 France
      • 9.6.5.1 Key Country Dynamics
      • 9.6.5.2 France Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.6 Spain
      • 9.6.6.1 Key Country Dynamics
      • 9.6.6.2 Spain Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.7 Italy
      • 9.6.7.1 Key Country Dynamics
      • 9.6.7.2 Italy Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.8 Denmark
      • 9.6.8.1 Key Country Dynamics
      • 9.6.8.2 Denmark Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.9 Norway
      • 9.6.9.1 Key Country Dynamics
      • 9.6.9.2 Norway Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.6.9 Sweden
      • 9.6.9.1 Key Country Dynamics
      • 9.6.9.2 Sweden Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7 Asia Pacific
    • 9.7.1 Swot Analysis
    • 9.7.2 Asia Pacific Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.3 Japan
      • 9.7.3.1 Key Country Dynamics
      • 9.7.3.2 Japan Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.4 China
      • 9.7.4.1 Key Country Dynamics
      • 9.7.4.2 China Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.5 India
      • 9.7.5.1 Key Country Dynamics
      • 9.7.5.2 India Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.6 Australia
      • 9.7.6.1 Key Country Dynamics
      • 9.7.6.2 Australia Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.7 South Korea
      • 9.7.7.1 Key Country Dynamics
      • 9.7.7.2 South Korea Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.7.8 Thailand
      • 9.7.8.1 Key Country Dynamics
      • 9.7.8.2 Thailand Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8 Latin America
    • 9.8.1 Latin America Swot Analysis
    • 9.8.2 Latin America Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.3 Brazil
      • 9.8.3.1 Key Country Dynamics
      • 9.8.3.2 Brazil Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.4 Mexico
      • 9.8.4.1 Mexico Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.8.5 Argentina
      • 9.8.5.1 Argentina Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.9 MEA
    • 9.9.1 MEA SWOT ANALYSIS
    • 9.9.2 MEA Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.9.3 South Africa
      • 9.9.3.1 Key Country Dynamics
      • 9.9.3.2 South Africa Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.9.4 Saudi Arabia
      • 9.9.4.1 Saudi Arabia Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.9.5 Kuwait
      • 9.9.5.1 Kuwait Veterinary Renal Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.9.6 UAE

Chapter 10 Competitive Landscape

  • 10.1 Participants' Overview
  • 10.2 Financial Performance
  • 10.3 Service Benchmarking
  • 10.4 Market Participant Categorization
  • 10.5 Estimated Market Position Analysis, 2022 (Heat Map Analysis)
  • 10.6 Strategy Mapping
    • 10.6.1 EXPANSION
    • 10.6.2 MERGERS & ACQUISITIONS
    • 10.6.3 PARTNERSHIPS & COLLABORATIONS
    • 10.6.4 SERVICE LAUNCHES/ EXPANSIONS
    • 10.6.5 OTHERS
  • 10.7 Company Profiles
    • 10.7.1. Mars inc.
      • 10.7.1.1. Participant's overview
      • 10.7.1.2. Financial performance
      • 10.7.1.3. Product benchmarking
      • 10.7.1.4. Strategic initiatives
    • 10.7.2. Nestle Purina Petcare
      • 10.7.2.1. Participant's overview
      • 10.7.2.2. Financial performance
      • 10.7.2.3. Product benchmarking
      • 10.7.2.4. Strategic initiatives
    • 10.7.3. Hills Pet Nutrition.
      • 10.7.3.1. Participant's overview
      • 10.7.3.2. Financial performance
      • 10.7.3.3. Product benchmarking
      • 10.7.3.4. Strategic initiatives
    • 10.7.4. J M Smucker.
      • 10.7.4.1. Participant's overview
      • 10.7.4.2. Financial performance
      • 10.7.4.3. Product benchmarking
      • 10.7.4.4. Strategic initiatives
    • 10.7.5. General Mills
      • 10.7.5.1. Participant's overview
      • 10.7.5.2. Financial performance
      • 10.7.5.3. Product benchmarking
      • 10.7.5.4. Strategic initiatives
    • 10.7.6. Zoetis Inc.
      • 10.7.6.1. Participant's overview
      • 10.7.6.2. Financial performance
      • 10.7.6.3. Product benchmarking
      • 10.7.6.4. Strategic initiatives
    • 10.7.7. Merck & Co. Inc.
      • 10.7.7.1. Participant's overview
      • 10.7.7.2. Financial performance
      • 10.7.7.3. Product benchmarking
      • 10.7.7.4. Strategic initiatives
    • 10.7.8. Elanco.
      • 10.7.8.1. Participant's overview
      • 10.7.8.2. Financial performance
      • 10.7.8.3. Product benchmarking
      • 10.7.8.4. Strategic initiatives
    • 10.7.9. Phibro Animal Health Corporation.
      • 10.7.9.1. Participant's overview
      • 10.7.9.2. Financial performance
      • 10.7.9.3. Product benchmarking
      • 10.7.9.4. Strategic initiatives
    • 10.7.10. Ceva Sante Animale
      • 10.7.10.1. Participant's overview
      • 10.7.10.2. Financial performance
      • 10.7.10.3. Product benchmarking
      • 10.7.10.4. Strategic initiatives
    • 10.7.11. Boehringer Ingelheim Animal Health
      • 10.7.11.1. Participant's overview
      • 10.7.11.2. Financial performance
      • 10.7.11.3. Product benchmarking
      • 10.7.11.4. Strategic initiatives
    • 10.7.12. Dechra Pharmceuticals
      • 10.7.12.1. Participant's overview
      • 10.7.12.2. Financial performance
      • 10.7.12.3. Product benchmarking
      • 10.7.12.4. Strategic initiatives
    • 10.7.13. VetPharma
      • 10.7.13.1. Participant's overview
      • 10.7.13.2. Financial performance
      • 10.7.13.3. Product benchmarking
      • 10.7.13.4. Strategic initiatives
    • 10.7.14. Vedco Inc.
      • 10.7.14.1. Participant's overview
      • 10.7.14.2. Financial performance
      • 10.7.14.3. Product benchmarking
      • 10.7.14.4. Strategic initiatives
    • 10.7.15. Mission Pharmacal Company
      • 10.7.15.1. Participant's overview
      • 10.7.15.2. Financial performance
      • 10.7.15.3. Product benchmarking
      • 10.7.15.4. Strategic initiatives
    • 10.7.16. Rayne Clinical Nutrition
      • 10.7.16.1. Participant's overview
      • 10.7.16.2. Financial performance
      • 10.7.16.3. Product benchmarking
      • 10.7.16.4. Strategic initiatives
    • 10.7.17. Neogen Corporation.
      • 10.7.17.1. Participant's overview
      • 10.7.1.2. Financial performance
      • 10.7.17.3. Product benchmarking
      • 10.7.17.4. Strategic initiatives
    • 10.7.18. Roquette Freres
      • 10.7.18.1. Participant's overview
      • 10.7.18.2. Financial performance
      • 10.7.18.3. Product benchmarking
      • 10.7.18.4. Strategic initiatives
    • 10.7.19. JP Farma
      • 10.7.19.1. Participant's overview
      • 10.7.19.2. Financial performance
      • 10.7.19.3. Product benchmarking
      • 10.7.19.4. Strategic initiatives
    • 10.7.20. Richmond Vet Pharma
      • 10.7.20.1. Participant's overview
      • 10.7.20.2. Financial performance
      • 10.7.20.3. Product benchmarking
      • 10.7.20.4. Strategic initiatives
    • 10.7.21. IDEXX Laboratories Inc.
      • 10.7.21.1. Participant's overview
      • 10.7.21.2. Financial performance
      • 10.7.21.3. Product benchmarking
      • 10.7.21.4. Strategic initiatives
    • 10.7.22. Fujifilm Holdings Corporation
      • 10.7.22.1. Participant's overview
      • 10.7.22.2. Financial performance
      • 10.7.22.3. Product benchmarking
      • 10.7.22.4. Strategic initiatives
    • 10.7.23. Carestream Health.
      • 10.7.23.1. Participant's overview
      • 10.7.23.2. Financial performance
      • 10.7.23.3. Product benchmarking
      • 10.7.23.4. Strategic initiatives
    • 10.7.24. Mindray Bio-Medical Electronics Co., Ltd.
      • 10.7.24.1. Participant's overview
      • 10.7.24.2. Financial performance
      • 10.7.24.3. Product benchmarking
      • 10.7.24.4. Strategic initiatives

Chapter 11 Key Takeaways

List of Tables

  • Table 1 Country share estimation
  • Table 2 List of market players
  • Table 3 North America Veterinary Renal Diseases market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 5 North America Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 6 North America Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 7 North America Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 8 North America Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 US Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 10 US Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 11 US Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 12 US Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 13 US Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 14 Canada Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 16 Canada Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 17 Canada Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 18 Canada Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 Europe Veterinary Renal Diseases market, by region, 2017- 2030 (USD Million)
  • Table 20 Europe Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 22 Europe Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 23 Europe Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 24 Europe Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 25 UK Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 26 UK Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 27 UK Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 28 UK Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 29 UK Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Germany Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 31 Germany Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 32 Germany Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 33 Germany Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Germany Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 35 Italy Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 36 Italy Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 37 Italy Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 38 Italy Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 39 Italy Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 40 France Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 41 France Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 42 France Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 43 France Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 44 France Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 Spain Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 46 Spain Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 47 Spain Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 48 Spain Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 49 Spain Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50 Denmark Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Denmark Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 52 Denmark Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million
  • Table 53 Denmark Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 54 Denmark Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 Sweden Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 56 Sweden Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 57 Sweden Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 58 Sweden Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 59 Sweden Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 60 Norway Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 61 Norway Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 62 Norway Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 63 North America Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 64 Norway Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Veterinary Renal Diseases market, by region, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 71 Japan Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 72 Japan Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 73 Japan Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 74 Japan Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 75 Japan Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 76 China Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 77 China Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 78 China Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 79 China Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 80 China Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 81 India Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 82 India Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 83 India Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 84 India Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 85 India Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 86 Australia Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 87 Australia Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 88 Australia Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 89 North America Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 90 Australia Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 91 Thailand Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 92 Thailand Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 93 Thailand Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 94 Thailand Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 95 Thailand Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 96 South Korea Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 97 South Korea Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 98 South Korea Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 99 South Korea Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 100 South Korea Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 101 Latin America Veterinary Renal Diseases market, by region, 2018 - 2030 (USD Million)
  • Table 102 Latin America Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 103 Latin America Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 104 Latin America Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 105 Latin America Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 106 Latin America Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 107 Brazil Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 108 Brazil Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 109 Brazil Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 110 Brazil Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 111 Brazil Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 112 Mexico Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 113 Mexico Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 114 Mexico Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 115 Mexico Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 116 Mexico Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 117 Argentina Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 118 Argentina Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 119 Argentina Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 120 Argentina Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 121 Argentina Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 122 MEA Veterinary Renal Diseases market, by region, 2018 - 2030 (USD Million)
  • Table 123 MEA Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 124 MEA Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 125 MEA Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 126 MEA Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 127 MEA Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 128 South Africa Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 129 South Africa Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 130 South Africa Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 131 South Africa Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 132 South Africa Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 137 Saudi Arabia Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 138 UAE Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 139 UAE Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 140 UAE Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 141 UAE Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 142 UAE Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 143 Kuwait Veterinary Renal Diseases market, by Type, 2018 - 2030 (USD Million)
  • Table 144 Kuwait Veterinary Renal Diseases market, by animal type, 2018 - 2030 (USD Million)
  • Table 145 Kuwait Veterinary Renal Diseases market, by route of administration, 2018 - 2030 (USD Million)
  • Table 146 Kuwait Veterinary Renal Diseases market, by indication, 2018 - 2030 (USD Million)
  • Table 147 Kuwait Veterinary Renal Diseases market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 148 List of secondary sources
  • Table 149 List of emerging companies
  • Table 150 Canine, Feline, Equine & Bovine population (in millions)

List of Figures

  • Fig. 1 Veterinary Renal Diseases market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Data analysis models
  • Fig. 6 Market formulation and validation
  • Fig. 7 Data validating & publishing
  • Fig. 8 Commodity flow analysis
  • Fig. 9 Volume-price market analysis: veterinary renal diseases services market
  • Fig. 10 Ancillary market analysis
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Parent market outlook
  • Fig. 16 Ancillary market outlook
  • Fig. 17 Demographics of American pet owners, based on generation, %, 2022
  • Fig. 18 Demographics of American pet owners, based on generation, %, 2023
  • Fig. 19 veterinary renal diseases market dynamics
  • Fig. 20 veterinary renal diseases market: PORTER's analysis
  • Fig. 21 veterinary renal diseases market: PESTEL analysis
  • Fig. 22 veterinary renal diseases market by Type: Key takeaways
  • Fig. 23 veterinary renal diseases market by Type, market share, 2023 & 2030
  • Fig. 24 Diagnosis market, 2018 - 2030 (USD Million)
  • Fig. 25 Treatment, 2018 - 2030 (USD Million)
  • Fig. 26 Drugs market, 2018 - 2030 (USD Million)
  • Fig. 27 veterinary renal diseases market by animal type: Key takeaways
  • Fig. 28 veterinary renal diseases market by animal type, market share, 2023 & 2030
  • Fig. 29 Canine market, 2018 - 2030 (USD Million)
  • Fig. 30 Feline market, 2018 - 2030 (USD Million)
  • Fig. 31 Bovine market, 2018 - 2030 (USD Million)
  • Fig. 32 Equine market, 2018 - 2030 (USD Million)
  • Fig. 33 Others market, 2018 - 2030 (USD Million)
  • Fig. 34 veterinary renal diseases market by route of administration: Key takeaways
  • Fig. 35 veterinary renal diseases market by route of administration, market share, 2023 & 2030
  • Fig. 36 Oral market, 2018 - 2030 (USD Million)
  • Fig. 37 Injectable market, 2018 - 2030 (USD Million)
  • Fig. 38 veterinary renal diseases market by indication: Key takeaways
  • Fig. 39 veterinary renal diseases market by Indication, market share, 2023 & 2030
  • Fig. 40 Renal Failure market, 2018 - 2030 (USD Million)
  • Fig. 41 Chronic Kidney Disease (CKD) market, 2018 - 2030 (USD Million)
  • Fig. 42 Renal Cystitis market, 2018 - 2030 (USD Million)
  • Fig. 43 Kidney Stones market, 2018 - 2030 (USD Million)
  • Fig. 44 Nephritis market, 2018 - 2030 (USD Million)
  • Fig. 45 Others market, 2018 - 2030 (USD Million)
  • Fig. 46 Veterinary Renal Diseases market by Distribution channel: Key takeaways
  • Fig. 47 Veterinary Renal Diseases market by distribution channel, market share, 2023 & 2030
  • Fig. 48 Veterinary hospitals & clinics market, 2018 - 2030 (USD Million)
  • Fig. 49 Pet Specialty Stores market, 2018 - 2030 (USD Million)
  • Fig. 50 E-commerce market, 2018 - 2030 (USD Million)
  • Fig. 51 Others market, 2018 - 2030 (USD Million)
  • Fig. 52 veterinary renal diseases market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 53 Regional market share analysis, 2023 & 2030
  • Fig. 54 Regional marketplace: key takeaways
  • Fig. 55 Regional marketplace: key takeaways
  • Fig. 56 North America: SWOT analysis
  • Fig. 57 North America veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 U.S. veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Canada veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Europe: SWOT analysis
  • Fig. 63 Europe veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Germany veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 UK veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 France veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Spain veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Italy veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Denmark veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Fih.72 Key country dynamics
  • Fig. 77 Norway veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Sweden veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Asia Pacific SWOT Analysis
  • Fig. 81 Asia Pacific veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Japan veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 China veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 India veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Australia veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Korea veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Thailand veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 94 Latin America SWOT analysis
  • Fig. 95 Latin America veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Brazil veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 98 Mexico veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 99 Argentina veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 MEA SWOT analysis
  • Fig. 101 MEA veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 South Africa veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 Saudi Arabia veterinary renal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 UAE veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Kuwait veterinary renal diseases market, 2018 - 2030 (USD Million)
  • Fig. 110 Market participant categorization
  • Fig. 111 Heat map analysis
  • Fig. 112 Key strategies deployed by market players